Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

14.25p
   
  • Change Today:
      3.40p
  • 52 Week High: 15.23
  • 52 Week Low: 1.09
  • Currency: UK Pounds
  • Shares Issued: 499.72m
  • Volume: 24,054,090
  • Market Cap: £71.21m
  • RiskGrade: 328
  • Beta: 0.01

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £212,106
Lisa Baderoon 583,963 £83,215
Tim Franklin 525,000 £74,812

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 44,945,948 £6,404,798
Luca & Associates AG 22,000,000 £3,135,000
Invesco Ltd 17,872,341 £2,546,809
Aviva Investors Global 11,285,180 £1,608,138
Alora Pharmaceuticals LLC 10,909,091 £1,554,546
M&G Investments 7,600,000 £1,083,000
Prudential plc 7,600,000 £1,083,000
Capital Income Builder 4,870,367 £694,027
Dr R Zimmer 4,551,553 £648,596
Odey Asset Management 3,433,319 £489,248
Rhone Trustees (Switzerland) SA 3,386,000 £482,505
Pictet Overseas Trust Corporation Limited 3,287,500 £468,469

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 14.25p
Change Today 3.40p
% Change 31.34 %
52 Week High 15.23
52 Week Low 1.09
Volume 24,054,090
Shares Issued 499.72m
Market Cap £71.21m
Beta 0.01
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 12-Sep-2025

Time Volume / Share Price
16:25 100,000 @ 14.22p
16:34 876 @ 14.00p
16:30 2,952 @ 13.70p
16:16 133,633 @ 14.96p
16:34 981 @ 14.00p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page